Buyback yield (TTM)
0.02%
Shareholder yield (TTM)
0.92%
5Y share count change
10.2%
Buyback spend (TTM)
$3.94M
Cumulative buybacks
$2.62B
Key takeaways
- Albemarle (ALB) repurchased about $3.94M of stock over the trailing twelve months.
- Diluted share count is up 10.2% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 0.10× — repurchases only partially offset SBC dilution.
- TTM repurchases used about 1% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Albemarle (ALB)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Albemarle (ALB)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Albemarle (ALB)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Albemarle (ALB)
Latest: $0.00
Overview
Albemarle (ALB) most recent annual buyback spend stands at $0.00 (2025).
Albemarle buyback spend plunged from $582.30M in 2013 to $0.00 in 2025, a 100.0% drawdown.
The highest annual buyback spend of $582.30M was reported in 2013. The lowest in the available history was $0.00 in 1993.
Albemarle Buyback Spend 2025: $0.00
Albemarle buyback spend in 2025 was $0.00.
Albemarle Buyback Spend 2024: $0.00
Albemarle buyback spend in 2024 was $0.00.
Albemarle Buyback Spend 2023: $0.00
Albemarle buyback spend in 2023 was $0.00.
Albemarle Buyback Spend 2022: $0.00
Albemarle buyback spend in 2022 was $0.00.
Albemarle Buyback Spend 2021: $0.00
Albemarle buyback spend in 2021 was $0.00.
See more financial history for Albemarle (ALB).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $40.27M | −$40.27M | — | 0.12B | +0.2% | |
| 2024 | $0.00 | $32.14M | −$32.14M | — | 0.12B | -0.2% | |
| 2023 | $0.00 | $36.55M | −$36.55M | — | 0.12B | -0.0% | |
| 2022 | $0.00 | $30.47M | −$30.47M | — | 0.12B | +1.1% | |
| 2021 | $0.00 | $20.12M | −$20.12M | — | 0.12B | +9.1% | |
| 2020 | $0.00 | $22.84M | −$22.84M | — | 0.11B | +0.5% | |
| 2019 | $0.00 | $19.68M | −$19.68M | — | 0.11B | -2.9% | |
| 2018 | $500.00M | $15.23M | $484.77M | 6.12% | 0.11B | -2.6% | |
| 2017 | $250.00M | $19.40M | $230.60M | 1.77% | 0.11B | -0.8% | |
| 2016 | $0.00 | $17.03M | −$17.03M | — | 0.11B | +1.5% | |
| 2015 | $0.00 | $15.19M | −$15.19M | — | 0.11B | +41.0% | |
| 2014 | $150.00M | $14.27M | $135.73M | 3.19% | 0.08B | -6.2% | |
| 2013 | $582.30M | $10.16M | $572.13M | 11.31% | 0.08B | -6.2% | |
| 2012 | $63.58M | $15.21M | $48.36M | 1.15% | 0.09B | -1.8% | |
| 2011 | $178.13M | $27.07M | $151.06M | 3.89% | 0.09B | -0.7% | |
| 2010 | $14.95M | $15.69M | −$749.00K | 0.29% | 0.09B | +0.1% | |
| 2009 | $5.81M | $307.00K | $5.50M | 0.17% | 0.09B | -0.5% | |
| 2008 | $168.95M | $18.47M | $150.49M | 8.29% | 0.09B | -4.8% | |
| 2007 | $101.21M | $0.00 | $101.21M | 2.66% | 0.10B | +0.1% | |
| 2006 | $31.84M | $0.00 | $31.84M | 0.93% | 0.10B | +1.7% | |
| 2005 | $0.00 | $0.00 | $0.00 | — | 0.10B | +12.3% | |
| 2004 | $827.00K | $0.00 | $827.00K | 0.05% | 0.09B | +0.9% | |
| 2003 | $17.59M | $0.00 | $17.59M | 1.42% | 0.08B | -2.3% | |
| 2002 | $93.07M | $0.00 | $93.07M | 7.94% | 0.09B | -7.3% | |
| 2001 | $7.58M | $0.00 | $7.58M | 0.73% | 0.09B | -0.2% | |
| 2000 | $9.80M | $0.00 | $9.80M | — | 0.09B | -1.9% | |
| 1999 | $15.50M | $0.00 | $15.50M | — | 0.10B | -8.9% | |
| 1998 | $140.60M | $0.00 | $140.60M | — | 0.10B | -6.2% | |
| 1997 | $37.50M | $0.00 | $37.50M | — | 0.11B | -5.7% | |
| 1996 | $251.50M | $0.00 | $251.50M | — | 0.12B | — | |
| 1995 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — | |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — |
- 2025$0.00
- 2024$0.00
- 2023$0.00
- 2022$0.00
- 2021$0.00
- 2020$0.00
- 2019$0.00
- 2018$500.00M
- 2017$250.00M
- 2016$0.00
- 2015$0.00
- 2014$150.00M
- 2013$582.30M
- 2012$63.58M
- 2011$178.13M
- 2010$14.95M
- 2009$5.81M
- 2008$168.95M
- 2007$101.21M
- 2006$31.84M
- 2005$0.00
- 2004$827.00K
- 2003$17.59M
- 2002$93.07M
- 2001$7.58M
- 2000$9.80M
- 1999$15.50M
- 1998$140.60M
- 1997$37.50M
- 1996$251.50M
- 1995$0.00
- 1994$0.00
- 1993$0.00
Buybacks vs stock-based compensation for Albemarle (ALB)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.10×.
Buybacks vs dividends (share of cash returned) for Albemarle (ALB)
How Albemarle splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Albemarle, ranked by their latest buyback spend.
| $4.60B | |
| $2.30B | |
| $1.66B | |
| $1.18B | |
| $783.80M | |
| $682.89M | |
| $107.00M | |
| $0.00 |
- $4.60B
- $2.30B
- $1.66B
- $1.18B
- $783.80M
- $682.89M
- $107.00M
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $386.69M (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation